Search results 1-2 of 2 in Irritable Bowel Syndrome (IBS)
Results
-
Rochester, Minn.
View Summary
Effects of Mexiletine on Colonic Transit in a Patient With Irritable Bowel Syndrome - Constipation (IBS-C)
Location:
Rochester, Minn.
Trial status:
Open for Enrollment
Why is this study being done?
To understand if Mexiletine will restore normal colonic motility in a patient with a missense mutation in SCN5A, which encodes a voltage-sensitive sodium channel NaV1.5 as it is known to rescue certain expression defects of NaV1.5 in vitro.
NCT ID:
NCT01717404
IRB Number:
12-006842
Who can I contact for additional information about this study?
-
Rochester, Minn.
View Summary
A Placebo-Controlled Trial of Pregabalin (Lyrica) for Irritable Bowel Syndrome
Location:
Rochester, Minn.
Trial status:
Open for Enrollment
Why is this study being done?
This study is being done to see if Lyrica helps people with irritable bowel syndrome, otherwise known as "IBS". Lyrica is the trade name for pregabalin, which was first approved by the FDA in June 2005 and has been available through prescription since fall 2005, and is marketed by Pfizer. Lyrica is known to have clinical efficacy treating pain disorders including IBS-related conditions such as fibromyalgia.
NCT ID:
NCT00977197
IRB Number:
09-004404
Who can I contact for additional information about this study?
Rochester: Annie Almazar 507-284-5010